Nonspecific low back pain
Conditions
Interventions
Control group:1 patch each time 12 hours each time
Apply to the affected area twice a day
Experimental group:10 ml at a time 1 time a day. Soak the liquid medicine on the compress and apply it to the affected area for 60 minutes
Sponsors
The Third Affiliated Hospital of Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Meets diagnostic criteria for chronic pain of the musculoskeletal system and chronic non-specific low back pain 2.It meets the TCM syndrome differentiation standards of cold coagulation and blood stasis pattern (cold pattern and stasis pattern) 3.The most painful NRS score in the 24 hours prior to enrollment = 4 points 4.Age 18-80 years 5.Those who agree to participate in this clinical study and sign the informed consent form
Exclusion criteria
Exclusion criteria: 1.Patients with spine-specific diseases (such as infections tumors fractures spinal deformities ankylosing spondylitis etc.) neurological diseases (such as spinal cord tumors cauda equina tumors etc.) urological diseases (such as overflow urinary incontinence and urinary retention) vascular diseases (such as abdominal aortic dissection aneurysm etc.) 2.Patients with anxiety disorders depressive disorders and psychiatric disorders such as schizophrenia 3.Patients with bronchial asthma 4.Patients with coronary artery bypass grafting (CABG) active peptic ulcer/hemorrhage severe heart failure 5.Patients with other severe heart brain liver kidney blood and other systemic diseases and immunodeficiency 6.Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) > 2 times the upper limit of normal and serum creatinine (Scr) > upper limit of normal 7.Pregnant or lactating women 8.Those who are known to be allergic to the test drug and its ingredients alcohol celecoxib sulfonamide and flurbiprofen preparations 9.skin breakdowns lesions or infected areas; Rheumatoid patients have red swollen hot and painful joints 10.Participation in other clinical studies within 1 month prior to screening 11.Those who are considered by the investigator to be inappropriate to participate in this clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Degree of pain relief (NRS score change from baseline); | — |
Countries
China
Contacts
Public ContactWeiheng Chen
The Third Affiliated Hospital of Beijing University of Chinese Medicine
Outcome results
None listed